Gupta Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$381K Buy
1,465
+91
+7% +$24K 0.09% 165
2015
Q4
$421K Sell
1,374
-189
-12% -$54.3K 0.11% 155
2015
Q3
$456K Buy
1,563
+124
+9% +$40.9K 0.11% 145
2015
Q2
$581K Buy
1,439
+15
+1% +$6.02K 0.14% 129
2015
Q1
$601K Buy
+1,424
New +$561K 0.18% 115

Other funds holding BIIB

Gupta Wealth Management's BIIB Position: Q1 2016 in Review

Gupta Wealth Management increased its Biogen (BIIB) stake by 6.6% in Q1 2016, buying an estimated $24K and bringing the position to 1,465 shares worth $381K. The position accounts for 0.09% of the portfolio, ranked #165.

Gupta Wealth Management first reported a position in BIIB in Q1 2015 and has held it in 5 quarters since. The position peaked at $601K in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Gupta Wealth Management held 1,465 shares of Biogen worth $381K as of Q1 2016.
  • Gupta Wealth Management bought 91 Biogen shares in Q1 2016, an estimated $24K.
  • Biogen made up 0.09% of Gupta Wealth Management's portfolio in Q1 2016, its #165 holding.
  • Gupta Wealth Management first reported a position in Biogen in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's Biogen position peaked at $601K in Q1 2015.
  • 948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.